Editorial comment: The connection between the biology of nitric oxide (NO), the principal mediator of penile erection, and the erectile dysfunction of diabetes mellitus has commonly been that of decreased content of both neuronal and endothelial NO synthases in the diseased penis and, therefrom, decreased local production of NO by these isoenzymes. Recent evidence has demonstrated that arginase, which competes for the same substrate L-arginine as NOS, is expressed in human corpus cavernosum and its inhibition facilitates NO-dependent relaxation of penile corpus cavernosum smooth muscle. In light of this knowledge, these investigators hypothesized that the biology of arginase is dysregulated in diabetic penile tissue contributing to altered NO synthesis in the corpora cavernosa of the diabetic penis. Their investigation consisted of evaluating arginase gene expression, protein levels, and enzyme activity comparatively in both diabetic and normal human cavernosal tissue. They found that all parameters of arginase II, but not arginase I, are increased in diabetic tissue, and inhibition of arginase activity reversed the reduction in NO synthesis in this tissue. The findings support an alternative mechanism for impaired NO-dependent penile erection in diabetogenic erectile dysfunction. They also expand concepts of NO biological regulation in the penis and foster new therapeutic possibilities on this basis for erectile dysfunction.
Editorial comment: The connection between the biology of nitric oxide (NO), the principal mediator of penile erection, and the erectile dysfunction of diabetes mellitus has commonly been that of decreased content of both neuronal and endothelial NO synthases in the diseased penis and, therefrom, decreased local production of NO by these isoenzymes. Recent evidence has demonstrated that arginase, which competes for the same substrate L-arginine as NOS, is expressed in human corpus cavernosum and its inhibition facilitates NO-dependent relaxation of penile corpus cavernosum smooth muscle. In light of this knowledge, these investigators hypothesized that the biology of arginase is dysregulated in diabetic penile tissue contributing to altered NO synthesis in the corpora cavernosa of the diabetic penis. Their investigation consisted of evaluating arginase gene expression, protein levels, and enzyme activity comparatively in both diabetic and normal human cavernosal tissue. They found that all parameters of arginase II, but not arginase I, are increased in diabetic tissue, and inhibition of arginase activity reversed the reduction in NO synthesis in this tissue. The findings support an alternative mechanism for impaired NO-dependent penile erection in diabetogenic erectile dysfunction. They also expand concepts of NO biological regulation in the penis and foster new therapeutic possibilities on this basis for erectile dysfunction.
